RxDoctor Payments Data

Willie Edwards, MD

Orthopaedic Surgery of the Spine · Florence, SCNPI 1134129216

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $681,965 of the $687,406 with a category attached, or 99.2%. Degen Medical, Inc. accounts for 99.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $160,575 and has fallen 54.3% since, to $73,389 in 2025.

$687,406in general payments, 2019–2025

Across 77 payments — averaging $8927.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Degen Medical, Inc.$686K
  • Medtronic$411
  • Globus Medical$193
  • Pacira Pharmaceuticals Incorporated$104
  • Boston Scientific$101
  • Brainlab, Inc.$60
  • plus $77 from 3 others

What the payments were for

  • Royalty or licence$681,96599%
  • Consulting fees$1,8000%
  • Travel & lodging$1,6660%
  • Food & beverage$1,9740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$687,406 in reported general payments places this provider in the 85th percentile of 32 orthopaedic surgery of the spine providers in South Carolina.

See all orthopaedic surgery of the spine providers in South Carolina

Medicare billing

Part B allowed, 2024
$214,292
Medicare patients
304
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcitonin-SalmonCalcitonin,salmon,synthetic14$859
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$613
Tizanidine Hcl64$612
Gabapentin29$197
Methylprednisolone25$186
Tramadol Hcl29$136
Meloxicam19$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →